DNA topoisomerase I from Mycobacterium smegmatis: an enzyme with distinct features by Bhaduri, Tisha et al.
DNA Topoisomerase I from Mycobacterium smegmatis
AN ENZYME WITH DISTINCT FEATURES*
(Received for publication, October 6, 1997, and in revised form, March 18, 1998)
Tisha Bhaduri‡, Tapan Kumar Bagui§, Devanjan Sikder, and Valakunja Nagaraja¶
From the Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India
A type I topoisomerase has been purified to homoge-
neity from Mycobacterium smegmatis. It is the largest
single subunit enzyme of this class having molecular
mass of 110 kDa. The enzyme is Mg21 dependent and can
relax negatively supercoiled DNA, catenate, and knot
single-stranded DNA, thus having typical properties of
type I topoisomerases. Furthermore, the enzyme makes
single-stranded nicks and the 5*-phosphoryl end of the
nicked DNA gets covalently linked with a tyrosine resi-
due of the enzyme. However, M. smegmatis enzyme
shows some distinctive features from the prototype
Escherichia coli topoisomerase I. The enzyme is rela-
tively stable at higher temperatures and not inhibited
by spermidine. It apparently does not contain any
bound Zn21 and on modification of cysteine residues
retains the activity, suggesting the absence of the zinc-
finger motif in DNA binding. Partially purified Mycobac-
terium tuberculosis topoisomerase I exhibits very simi-
lar properties with respect to size, stability, and
reaction characteristics. Sequence comparison of topoi-
somerase I from E. coli and M. tuberculosis shows the
absence of zinc-finger motifs in mycobacterial enzyme.
Using a two-substrate assay system, we demonstrate
that the enzyme acts processively at low ionic strength
and switches over to distributive mode at high Mg21
concentration. Significantly, the enzyme activity is
stimulated by single strand DNA-binding protein. There
is a potential to exploit the characteristics of the enzyme
to develop it as a molecular target against mycobacte-
rial infections.
DNA topoisomerases are ubiquitous enzymes that play a
vital role in variety of cellular processes by maintaining the
superhelical density of DNA (1). There are two distinct subfam-
ilies of topoisomerases. Type I subclass consists of prokaryotic
and eukaryotic topoisomerase I and topoisomerase III en-
zymes, which effect topological changes in DNA by transiently
cleaving one DNA strand at a time to allow the passage of
another strand (2). This results in the change in linking num-
ber of DNA by steps of one. Eukaryotic topoisomerase II, bac-
terial DNA gyrase, and topoisomerase IV belong to the type II
subfamily. The enzymes of the latter group require ATP for
catalysis and introduce transient double-stranded breaks,
changing the linking number in steps of two (2). Topoisomer-
ases have been found to participate in nearly all cellular trans-
actions involving DNA and thus can be the ideal target en-
zymes for clinical medicine. The identification of DNA gyrase
as a target for chemical inhibitors, antibiotics, toxins (3–5), and
eukaryotic topoisomerases for a large number of anticancer
agents (6) illustrates this point well.
The prokaryotic topoisomerase I has been extensively char-
acterized from Escherichia coli (7, 8). Topoisomerase I from few
other bacterial sources such as Micrococcus luteus (9), Diplo-
coccus pneumoniae (10), and Fervidobacterium islandicum (11)
have also been studied. Prokaryotic type I topoisomerases cat-
alyze the relaxation of negatively supercoiled DNA in an en-
ergy independent manner. Other reactions catalyzed by this
class of enzymes include knotting and catenation of single-
stranded DNA or duplex DNA having a nick in one of the
strands. It is suggested that in prokaryotes, topoisomerase I
plays a crucial role to maintain the in vivo superhelical density
of DNA in conjunction with the supercoiling activity of DNA
gyrase (12). Topoisomerase I has been also implicated to have
role in DNA replication, transcription, and recombination
events (13). In certain pathogenic bacteria, regulation of viru-
lence gene expression seem to be mediated by topoisomerases
(14).
The genus Mycobacterium is of immense importance as My-
cobacterium tuberculosis, Mycobacterium leprae, and other op-
portunistic pathogenic strains belong to this group. Two major
diseases, tuberculosis and leprosy, continue to be serious
health hazards in all the developing countries. Reappearance of
tuberculosis in the Western world in the recent times and
emergence of multiple drug resistant M. tuberculosis clinical
strains have raised a global concern (15). There has been a
dramatic increase in the occurrence of tuberculosis in human
immunodeficiency virus-infected people, since the viral infec-
tion reduces the immunity in AIDS patients. These develop-
ments necessitate the identification of new molecular targets
as a prelude to the drug discovery.
While therapeutic agents targeted toward prokaryotic topoi-
somerase I have not been realized yet, this class of enzymes
remain as potential targets for a new class of inhibitors. Com-
pared with many other bacterial species very little is known
about the macromolecular events in mycobacteria. Thus, in
addition to exploring it as a molecular target, detailed charac-
terization of topoisomerase I from mycobacteria is also impor-
tant to understand the basic biology of the organism. Compar-
atively slow growth rate of mycobacteria and their ability to lay
dormant in host macrophages (15) is suggestive of some un-
usual regulatory features of DNA transaction events, which in
turn may be related to the DNA modulating enzymes like
topoisomerases.
In this article we report the detailed characterization of
topoisomerase I from M. smegmatis. The enzyme in many re-
spects, is similar to that of the prokaryotic prototype, charac-
terized from E. coli topoisomerase I. Yet, it exhibits some
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distinct properties. Our analysis, quite unexpectedly, indicates
that cysteines do not play a role in DNA binding.
EXPERIMENTAL PROCEDURES
Chemicals and Enzymes—Polyethyleneimine, NEM,1 MMTS, DTT,
spermidine, yeast tRNA, proteinase K, o-phenanthroline, phos-
phoamino acid markers were obtained from Sigma. Buffers, solutions,
and gel electrophoresis reagents were prepared using reagents from
Life Technologies, Inc. SP-Sepharose and Q-Sepharose column materi-
als were obtained from Pharmacia Biotech Inc. and phosphocellulose
from Whatman. Micrococcal nuclease was purchased from Worthing-
ton. SSB protein was purchased from Bangalore Genie Ltd., India.
Radioactive nucleoside triphosphates with specific activity 3000 Ci/
mmol were obtained from Amersham Corp.
Plasmid pJW312-SalI which was used for overexpressing E. coli
topoisomerase I, was a generous gift from James C. Wang, Harvard
University, Cambridge, MA. E. coli topoisomerase I was purified using
the published protocol (16).
Purification of Topoisomerase I from M. smegmatis—Topoisomerase
I activity was purified from M. smegmatis. Growth of M. smegmatis SN2
and preparation of the cells for cell-free extracts are as described before
(17). The crude cell extract was centrifuged at 18,000 rpm and the
supernatant was centrifuged at 40,000 rpm in a Beckman type 50 Ti
rotor for 3 h, to obtain 100,000 3 g supernatant (S100). This S100
supernatant was brought to 1% final concentration of polyethylenei-
mine, in the presence of 50 mM NaCl. The polyethyleneimine superna-
tant was subjected to 0–67% ammonium sulfate fractionation. The
pellet was dissolved in buffer A (50 mM KPO4, pH 7.4, 1 mM EDTA, 5%
glycerol, 10 mM b-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluo-
ride, and 50 mM KCl) and loaded onto a phosphocellulose column (150
ml). The bound proteins were eluted with a salt gradient of 200 mM to
1 M KCl. The active fractions (eluted at 450 to 650 mM KCl) were pooled,
dialyzed (against buffer A), and subsequently loaded on to a SP-Sepha-
rose column (30 ml). Elution of the column was with a salt gradient of
400 to 750 mM KCl in buffer A and active fractions corresponding to 450
to 500 mM KCl were pooled and dialyzed against buffer B (50 mM
Tris-HCl, pH 8.0, 1 mM EDTA, 5% glycerol, 10 mM b-mercaptoethanol,
0.1 mM phenylmethylsulfonyl fluoride, and 50 mM KCl) and finally
loaded onto a Q-Sepharose column (10 ml). The column was developed
with linear gradient of buffer B having 50 to 600 mM KCl. The enzy-
matically active fractions eluted between 300 and 400 mM were pooled
and dialyzed against storage buffer (50 mM Tris-HCl, pH 8.0, 1 mM
EDTA, 20% glycerol, and 10 mM b-mercaptoethanol) and stored at
220 °C. Topoisomerase I from M. tuberculosis H37Ra was partially
purified (phosphocellulose chromatography) employing the procedure
described above.
The topoisomerase relaxation assay was carried out as described
before (17). One unit of enzyme catalyzes 50% conversion of 500 ng of
supercoiled pUC19 DNA into different relaxed topoisomers at 37 °C in
30 min under standard assay conditions.
Catenation Assay—Catenation of M13 single-stranded DNA was car-
ried out in a 20-ml reaction volume containing 20 mM Tris-HCl, pH 7.6,
20 mM KCl, 6 mM MgCl2, 5 mM spermidine, 0.5 mM DTT, 50 mg/ml
bovine serum albumin, 30% (v/v) glycerol, and 500 ng of DNA substrate.
Incubation was at 37 and 52 °C for 1 h. Products were extracted with
phenol-chloroform, and precipitated with alcohol before loading onto
0.8% agarose gel.
Processive and Distributive Mode of Relaxation Using Two Sub-
strates—The relaxation reaction was carried out with one of the sub-
strates with different concentrations of MgCl2 for 10 min, with limiting
enzyme concentration (0.2 units). Then the second substrate was added
and the reactions were continued for another 10 min. Reactions were
stopped with 1% SDS containing buffer and fractionated on a 1.2%
agarose gel. Bands were visualized after ethidium bromide staining.
Transfer of Radioactivity from DNA to Enzyme—pUC19 DNA in 20
mM Tris-HCl, pH 8.0, and 0.1 mM EDTA was nick-translated using
[a-32P]dATP and [a-32P]dCTP (specific activity of labeling was 2 3 107
cpm/mg of DNA). The DNA was denatured by adding NaOH to a final
concentration of 50 mM. After 10 min at 37 °C, the DNA was neutralized
with 50 mM HCl and 0.1 volume of 1 M Tris-HCl, pH 8.0. A reaction
mixture of 25 ml containing 20 mM Tris-HCl, pH 8.0, 20 mM NaCl, 50
mg/ml bovine serum albumin, 25 ng of denatured nick-translated DNA,
and the topoisomerase I enzyme was incubated at 37 °C for 30 min.
NaOH was added to a final concentration of 50 mM. Following incuba-
tion for an additional 10 min at 37 °C, the pH of the sample was
readjusted to 8.0. CaCl2 and micrococcal nuclease were added to a final
concentration of 1 mM and 5 units/ml, respectively. The mixture was
incubated overnight at 37 °C. The samples (protein-labeled nucleotide
complex) were analyzed in a SDS-polyacrylamide gel electrophoresis
followed by autoradiography.
Covalent Attachment of the Enzyme at the 59 End of the DNA Nicks—
The experiment was carried out with minor modifications of the de-
scribed procedure (18). 50-ml reaction mixtures containing 20 mM Tris-
HCl, pH 8.0, 20 mM NaCl, 1 mM EDTA, 100 ng of either 39-end filled or
59-end labeled Sau3AI-digested pUC19 DNA (alkali denatured) was
incubated at 37 °C for 1 h in the presence or absence of purified topoi-
somerase I. The reaction was stopped by adding 100 ml of a prewarmed
solution containing 0.2 M NaOH, 2% SDS, 2 mM EDTA, 50 mg/ml tRNA.
Samples were incubated for an additional 10 min at 37 °C, then neu-
tralized by adding 50 ml of a solution containing, 0.4 M HCl, 0.4 M
Tris-HCl, pH 8.0, and 0.25 M KCl and placed on ice for 10 min. Samples
were then centrifuged at 12,000 rpm for 20 min at 4 °C. The resulting
pellet was resuspended and washed with 200 ml of a solution containing
10 mM Tris-HCl, pH 8.0, 100 mM KCl, and 50 mg/ml tRNA at 65 °C.
After 10 min samples were cooled on ice and recentrifuged. After two
washes, pellets were resuspended in 200 ml of water by heating to 65 °C.
The radioactivity in the suspension was estimated in a scintillation
counter.
Identification of the Covalent Linkage—The protein-DNA complex,
prepared as described in the earlier section, was precipitated with
ice-cold acetone and free label was removed by repeated washing with
80% acetone. The precipitated protein-DNA complex was then proteo-
lyzed with 50 mg/ml proteinase K at 37 °C for 1 h. The digested product
was vacuum dried and resuspended in 100 ml of 5.6 M HCl. Hydrolysis
was performed at 110 °C for 1 h. HCl was removed in vacuum and the
dried hydrolysate was suspended in 15 ml of chromatographic buffer
(375 ml of n-butanol, 250 ml of pyridine, 75 ml of acetic acid). Samples
were spotted on a silica gel plate. Phosphoamino acid markers (phos-
photyrosine, phosphoserine, and phosphothreonine) were also spotted
on the same horizontal line. Thin layer chromatography, ninhydrin
staining, autoradiography of the resolved radiolabeled amino acids, etc.
were carried out according to the published procedures (19).
Modification of Cysteine Residues—Pure topoisomerase I (2–5 mM)
was denatured by 6 M guanidium HCl treatment at 37 °C for 1 h. One
aliquot of this denatured protein was sequentially dialyzed against the
assay buffer (Tris-HCl, pH 8.0, 20 mM NaCl, 5 mM MgCl2, 1 mM EDTA,
and 50 mM ZnCl2) containing 4, 2, of 1 M, and no guanidium HCl,
respectively, to renature the protein. The remainder of the denatured
protein was aliquoted and different aliquots were treated either with 1
mM NEM or 200 mM MMTS at 37 °C for 30 min. The NEM/MMTS-
treated proteins were dialyzed in the same way against the assay buffer
in the presence or absence of DTT. All the dialyzed fractions were
assayed for DNA relaxation activity. Complete modification of cysteine
residues was assessed by 5,59-dithio(nitrobenzoic acid) estimation of
free thiols (20, 21). Purified E. coli topoisomerase I (5 mM) was also
subjected to similar treatments.
Estimation of Cysteine Residues—Determination of the free thiols
was carried out by Ellman assay (20), essentially as described (21). 3
nmol of M. smegmatis topoisomerase I was diluted in 1 ml of 0.1 M
phosphate buffer and treated with 100 ml of 10 mM 5,59-dithio(nitroben-
zoic acid). Molar concentration of cysteine was calculated from the
DA412 nm as described (21). The value obtained was divided by the moles
of the enzyme used to obtain the number of free thiols present in the
protein.
Other Methods—Protein concentration was estimated at different
stages of purification using the procedure of Bradford (22), using bovine
serum albumin as standard. SDS-gel electrophoresis were carried out
according to Laemmli (23). Standard DNA manipulations and autora-
diography was carried out using established protocols (24). M13 single-
stranded DNA was prepared using standard procedure and purified
through a 5–30% sucrose density gradient (24). N-terminal sequencing
of the protein was carried out in Central Protein Sequencing Facility of
Indian Institute of Science using Shimadzu Gas Phase Sequenator
PSQ-1.
RESULTS
Purification of the Enzyme—The purification scheme of a
topoisomerase activity from M. smegmatis is presented in Fig.
1a. The protein fractions from different purification steps were
analyzed in a SDS-polyacrylamide gel. The protein appears to
1 The abbreviations used are: NEM, N-ethylmalamide; DTT, dithio-
threitol; MMTS, methyl methanethiosulfonate; SSB, single-stranded
DNA-binding protein.
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be homogeneous as it migrates as a single band corresponding
to the molecular mass of approximately 110 kDa in a silver-
stained gel (Fig. 1b). Thus the enzyme appears to be larger
than any of the prokaryotic type I topoisomerases character-
ized so far. The corresponding topoisomerase I from E. coli has
a molecular mass of 98 kDa (25). The purified topoisomerase I
from M. smegmatis was subjected to N-terminal sequence de-
termination by the Edman degradation method. The sequence
obtained, AGGSRGSGGA, is different from the N-terminal se-
quence of the E. coli enzyme and does not correspond to any
other topoisomerases.
The DNA relaxation assay was used to monitor the enzyme
activity at every stage of purification. The topoisomerase I
activity was purified to 1263-fold and the specific activity of the
enzyme was 2.17 3 105 units/mg of protein (Table I). The
purified DNA relaxation activity had salient features of a pro-
karyotic type I topoisomerases. The enzyme has an efficient
relaxation activity on negatively supercoiled DNA. Mg21 is
essential for the DNA relaxation activity, while nucleotide co-
factor(s) and monovalent cations are not required. However, at
higher salt concentrations (.250 mM) enzyme activity is abol-
ished. DNA relaxation activity of M. smegmatis topoisomerase
I was not inhibited at 0.5 or 1 mM spermidine (Fig. 2a, lanes 3
and 4. This is in contrast to the properties of E. coli topoisomer-
ase I which is inhibited at intracellular concentrations of the
spermidine (26). Our results with E. coli topoisomerase I is in
agreement with the earlier findings (26).
Thermal Stability of the M. smegmatis Topoisomerase I—To
check the thermo-tolerance of the M. smegmatis topoisomerase
I, standard assay mixtures were preincubated at different tem-
peratures and the reactions were initiated by the addition of
the enzyme. The results are presented in Fig. 2b. The myco-
bacterial enzyme retains some relaxation activity at 65 °C (lane
11), while the E. coli enzyme loses its activity above 42 °C
(lanes 4 and 5), indicating that the M. smegmatis topoisomer-
ase I is a more thermostable enzyme. Similar behavior is ob-
served with partially purified M. tuberculosis topoisomerase I
(not shown).
Positively Supercoiled DNA Is Not a Substrate—Topoisomer-
ase I from E. coli catalyzes the relaxation of negatively super-
coiled DNA but cannot use positively supercoiled substrates
(7), whereas both kinds of DNA are relaxed with comparable
efficiency by eukaryotic enzymes. The topoisomerase I from M.
smegmatis was tested for its ability to remove positive super-
coils, by comparing its relaxation activity with that of the E.
coli and calf thymus enzymes. Positively supercoiled DNA was
prepared by incubating relaxed DNA with 2 mg/ml ethidium
bromide. This concentration is not inhibitory to the relaxation
activity of the enzymes used. If the topoisomerase relaxes pos-
itive supercoils induced by ethidium bromide, the DNA would
acquire negative supercoils after removal of the dye. On the
other hand, if it failed to act on the positive supercoils, the
product DNA would not show any topological changes following
extraction of the dye molecule. This result shows that positive
supercoiled DNA is not a substrate for the M. smegmatis topoi-
somerase I (Fig. 3a, lanes 5 and 6), unlike the calf thymus
enzyme (lanes 7 and 8).
Catenation Reaction of Topoisomerase I—Prokaryotic topoi-
somerase I is known to catenate and knot single-stranded
circular DNA (27, 28). Fig. 3b, shows the result of the catena-
tion assay. M13 single-stranded DNA was used as the sub-
strate. Catenated structures of higher molecular weight were
observed at 52 °C (lanes 5 and 6). The catenanes were not
detectable when the DNA was incubated with the buffer also at
52 °C (lane 2) or when the enzymatic reaction was carried out
at 37 °C (lanes 3 and 4). Knotting assay was also performed
with M13 single-stranded DNA as substrate, which led to the
appearance of faster moving knotted molecules (data not
shown).
Analysis of the Processive Behavior of the Enzyme Employing
Two Substrates—The enzymes which operate on DNA exhibit
two different modes of interaction, distributive and processive.
Appearance of a large number of partially relaxed topoisomers
before fully relaxed product in a typical topoisomerase I reac-
tion, could be considered as distributive. In contrast, appear-
FIG. 1. Purification of the M. smegmatis topoisomerase I. a,
purification scheme. b, silver-stained SDS-polyacrylamide gel electro-
phoresis (10%) of the purified topoisomerase. Lanes 1 and 2, 100 and
250 ng of purified topoisomerase I, respectively. Molecular weight
markers are indicated by arrows.
TABLE I
Purification of M. smegmatis topoisomerase I
50 g of M. smegmatis SN2 cells were used.
Fractions Protein Activityunits
Specific
activity Purification
mg units/mg -fold
S20 584.65 NDa ND
S100 419.12 ND ND
(NH4)2SO4 232.8 4.0 3 10
4 171.8
Phosphocellulose 20.5 2.4 3 104 1.17 3 104 68.0
SP-Sepharose 0.125 1.1 3 104 8.0 3 104 465.6
Q-Sepharose 0.046 9982 2.17 3 105 1263.0
a ND, not determined.
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ance of fully relaxed product during the course of the reaction
while some supercoiled substrate still remains, indicates a
processive mode (2, 29). The effect of NaCl on the mode of
relaxation of M. smegmatis topoisomerase I is presented in Fig.
4. The enzyme shows a predominantly processive mode in the
absence of monovalent salts and gradually shifts to a distrib-
utive mode with the increase in the salt concentration (Fig. 4,
lanes 2–5). The results were similar when the influence of Mg21
concentration on the relaxation activity of the enzyme is stud-
ied. With the increase in Mg21 ion concentration there is an
increase in the number of partially relaxed topoisomers, which
reflects a distributive mode of action by the enzyme (not
shown).
The effect of Mg21 in changing topoisomerase I reaction from
processive to distributive mode was demonstrated by employ-
ing two plasmid substrates. The assay is initiated with one of
the supercoiled DNA substrates. The other substrate was
added during the course of the reaction as shown in the scheme
(Fig. 5a). In presence of higher concentration of Mg21 (5–7.5
mM) the enzyme shifts more efficiently to the second substrate
indicating a distributive mode of relaxation (Fig. 5, b and c).
The enzyme does not discriminate either of the plasmids as
both serve as efficient substrate when incubated together (not
shown). Furthermore, the distributive behavior is observed
irrespective of the order of addition of the plasmids (Fig. 5, b
and c).
Analysis of the Reaction Intermediate—DNA topoisomerases
have been shown to cleave the DNA phosphodiester bond and
simultaneously get covalently linked to DNA at the cleavage
site via a phosphotyrosine linkage (13). The formation of the
covalent complex can be assessed by trapping the reaction
intermediate followed by hydrolyzing the labeled DNA. This
would result in transfer of the label in the nucleotide to protein
(18). The active site residue involved in the protein-DNA link-
age can then be identified, upon hydrolysis of the protein.
Nick-translated, denatured pUC19 DNA was incubated with
M. smegmatis topoisomerase I and the DNA-protein covalent
intermediate was trapped by denaturing the protein with al-
kali. The DNA part of the complex was removed with micro-
coccal nuclease treatment, so that only the covalently linked
nucleotide is attached to the protein (Fig. 6a). The partially
purified M. tuberculosis topoisomerase I was subjected to such
an analysis. The topoisomerase from both species have similar
size and are larger than E. coli topoisomerase I. To identify the
FIG. 2. Properties of M. smegmatis topoisomerase I. a, effect of
spermidine. Topoisomerase I from M. smegmatis and E. coli (2 units
each) were assayed for relaxation activity with 500 ng of supercoiled
plasmid as substrate. Lanes 1 and 5, DNA alone; 0.5 mM (lanes 3 and 7)
and 1 mM (lanes 4 and 8) spermidine incubated with enzyme. M and D
represent the monomeric and dimeric forms of the supercoiled plasmid,
respectively. b, thermal stability of the M. smegmatis topoisomerase I.
Relaxation assay was carried out at the indicated temperatures for both
E. coli (lanes 1–5) and M. smegmatis (lanes 7–11) topoisomerase I. C
indicates the control reaction where the supercoiled DNA has been
incubated at 65 °C for 30 min (lane 6).
FIG. 3. a, relaxation of negatively and positively supercoiled DNA.
500 ng of negatively supercoiled DNA (Form I) (lane 1), was relaxed by
1 unit of M. smegmatis topoisomerase I in presence of 2 mg/ml ethidium
bromide (lane 2). 1 mg of relaxed pUC19 DNA (Form IV) was used as
substrate in lanes 3–8. All the assays mixtures contained 2 mg/ml
ethidium bromide, with 1 and 2 units of E. coli (lanes 3 and 4), M.
smegmatis (lanes 5 and 6), and calf thymus topoisomerase I (lanes 7 and
8), respectively. b, catenation assay with single-stranded M13 DNA.
M13 single-stranded DNA (lane 1) was incubated with the assay buffer
in absence of topoisomerase I at 52 °C (lane 2). The substrate was
incubated with 2, 4, and 6 units of enzyme at 37 °C (lanes 3, 4, and 5)
and at 52 °C (lanes 6, 7, and 8), respectively. The appearance of cat-
enanes are indicated by arrow (lanes 7 and 8).
FIG. 4. Effect of cations on processivity of the enzyme. Relax-
ation assays were performed with 500 ng of pUC19 supercoiled DNA
(lane 1) and 1 unit of enzyme (lanes 2–5) in the presence of 0 mM (lane
2), 10 mM (lane 3), 25 mM (lane 4), and 50 mM (lane 5) NaCl. All the
reaction mixtures contained 2 mM MgCl2.
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amino acid residue involved in the phosphoester bond forma-
tion with the DNA, the radiolabeled proteins (Fig. 6a) were
processed further as described under “Experimental Proce-
dures.” The active site residue was identified by autoradiogra-
phy of the thin layer chromatographic plate. Under our exper-
imental conditions, the radiolabeled amino acids from E. coli
and mycobacterial enzymes migrate at the same position (Fig.
6b, lanes 1 and 2). This result indicates that as in the case of
other topoisomerases, M. smegmatis enzyme also has a tyro-
sine at the active site.
The covalent complex formation described above could be
mediated either by the 39- or 59-end of nicked DNA. All the
known prokaryotic type I enzymes make 59 covalent contacts
while eukaryotic type I enzymes make 39 covalent linkage (19,
13). The experimental strategy to determine the linkage of M.
smegmatis enzyme is depicted in Fig. 7a. Determination of the
linkage could be established by employing DNA substrates
labeled either at 59-end or 39-end. Most of the radiolabel DNA-
protein complex was precipitated with an increase in enzyme
concentration when the 39-end labeled DNA substrates were
used. Proteinase K treatment of the reaction mixtures reduces
the precipitable counts, indicating that recoverable radioactiv-
ity is due to protein mediated complex formation. When 59-end
labeled DNA substrates were used, no appreciable complex
formation was observed (Fig. 7b). These results demonstrate
that covalent complex formation is mediated through the 59-
end of the nicked DNA.
Cysteines Are Not Involved in DNA Binding—E. coli topoi-
somerase I has zinc-finger structures at the C-terminal domain
of the enzyme which participates in DNA binding and cleavable
complex formation (30). This zinc coordination is via a cluster
of 12 cysteine residues. When these cysteine residues are mod-
ified, the enzyme loses its relaxation activity (31). To determine
whether cysteine residues have any role in the enzymatic ac-
tivity of the M. smegmatis enzyme, two cysteine modifiers,
NEM and MMTS, were used. NEM, a comparatively bulky
reagent irreversibly alkylates thiols. MMTS, on the other hand
brings about minimal steric change on modification and this
alkylation can be reversed with DTT (32). M. smegmatis en-
zyme was not inhibited by either of the modifiers, while the E.
coli enzyme was inhibited by MMTS but not NEM (Fig. 8a).
The topoisomerase I from M. smegmatis could be resistant to
inhibition due to the inaccessibility of the ligands to cysteines
in the native form of the enzyme. To test this possibility, both
M. smegmatis and E. coli enzymes were denatured with 6 M
guanidium HCl and treated with either NEM or MMTS. 5,59-
Dithio(nitrobenzoic acid) estimation for free thiols was carried
out to confirm complete modification. These modified proteins
were then renatured slowly to their native forms in the pres-
ence or absence of DTT. DTT can relieve the MMTS modifica-
FIG. 5. Enzyme switches over to distributive mode at high
Mg21 ion concentration. a, schematic diagram of the experiment. b,
relaxation reaction is carried out with plasmid pBR322 in presence of 2,
5, 7.5, and 10 mM MgCl2 (lanes 2, 3, 4, and 5) for 10 min with limiting
enzyme concentration (0.2 unit), followed by the addition of plasmid
pUC19. Lane 1 shows relaxation of pBR322 DNA in the presence 2 mM
MgCl2 for 10 min. c, relaxation assay was performed with pUC19 DNA
in absence of Mg21 (lane 1), or in the presence of 5 and 7.5 mM Mg21,
respectively (lanes 2 and 3). The second substrate, pBR322, was added
to the reaction mixture after 10 min in the presence of 5 mM (lane 4) and
7.5 mM (lane 5) MgCl2.
FIG. 6. Identification of the active site residue. a, DNA-topoi-
somerase I covalent complex was arrested for both E. coli and M.
smegmatis enzymes. Arrows indicate the position of the molecular
weight markers. b, the DNA-enzyme complexes for both E. coli (lane 1)
and M. smegmatis (lane 2) were digested with proteinase K and then
hydrolyzed. The resulting hydrolysates were analyzed by thin layer
chromatography and subsequently stained and autoradiographed. The
circles show the migration profile of the cold phosphoamino acid
markers.
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tion but not the cysteine-NEM adduct (32). Enzyme from all the
steps were assayed for the relaxation activity (Fig. 8b). The M.
smegmatis topoisomerase I is not inhibited by either of the
modifiers. On the other hand, E. coli topoisomerase I was
inhibited by both the modifiers and DTT treatment could re-
store the activity only in the case of MMTS modification (lane
13). Ellman assay (20, 21) for free thiols was carried out to
verify the complete modification of cysteines by MMTS and
NEM in both the proteins. These results strongly suggest that
cysteine residues do not contribute to M. smegmatis topoi-
somerase I activity. The primary amino acid sequence compar-
ison of E. coli (25) and M. tuberculosis (33) enzymes reveal a
difference in number and distribution of cysteine residues.
While 12 cysteine residues (out of 14) form 3 clusters of cysteine
(Fig. 9), none of those 12 residues are represented in mycobac-
terial enzyme. Only 5 cysteine residues found in the sequence
are distributed at different regions of 900 amino acid protein.
The Ellman assay (20) was used for the quantification of free
thiols of topoisomerase I from M. smegmatis employing the
standard assay conditions (21). Based on three independent
measurements (Table II), we estimate that five cysteines are
present per molecule of topoisomerase I of M. smegmatis. These
results are in agreement with the number of cysteine residues
found in the sequence of M. tuberculosis enzyme. Next, the
histidine modifier diethyl pyrocarbonate was used to determine
whether histidines could contribute for DNA binding. These set
of experiments also show that histidines do not play a role in
binding as DNA relaxation activity was not affected (data not
shown). No detectable signal was observed when the binding of
Zn21 was directly assessed by zinc blotting using radioactive
Zn21 (36).
Stimulation of DNA Relaxation Activity by Single Strand-
binding Protein—Type I topoisomerases from prokaryotes are
known to prefer single-stranded regions in DNA as substrates.
SSB binds and stabilizes the single-stranded region in a duplex
DNA. Thus it is conceivable that SSB could influence topoi-
somerase activity by stabilizing single-stranded regions in dou-
ble-stranded DNA. SSB was found to stimulate the relaxation
activity of the enzyme (data not shown). SSB was either pre-
incubated with the supercoiled DNA prior to the addition of
topoisomerase I or co-incubated with enzyme and DNA. In both
cases there was a stimulation in the relaxation activity of the
enzyme. When DNA:SSB molar ratio was increased to 1:8 there
was an inhibition of the enzyme activity (not shown).
DISCUSSION
In this article, we describe the detailed characterization of
topoisomerase I from M. smegmatis. Other than E. coli topoi-
somerase I which has been studied extensively with regard to
its structure, function, and mechanistics, detailed analysis
from other prokaryotic systems is lacking (13). Thus the results
presented here constitute an important study, also considering
the medical importance of genus mycobacteria.
Although chromatographic behavior of the topoisomerase I
from M. smegmatis is similar to the one from E. coli, the
enzyme is considerably larger. The N-terminal sequence of the
two enzymes are also different. Further comparison of the
FIG. 7. The enzyme makes covalent linkage with the 5*-end of
the nick. a, the experimental strategy. b, 59- (D) and 39- (l) end labeled
fragments were complexed with protein and the complex was precipi-
tated as described under “Experimental Procedures.” Proteinase K
treatment of the 39-end labeled-DNA-topoisomerase I complex and sub-
sequent KCl-SDS precipitation cannot recover any radioactivity (0).
FIG. 8. Effect of MMTS and NEM on topoisomerase activity. a,
MMTS and NEM inhibition of the M. smegmatis (lanes 2–6) and E. coli
topoisomerase I (lanes 7–11) DNA relaxation activity. Lanes 2 and 7, no
inhibitor; lanes 3 and 8, 100 mM MMTS; lanes 4 and 9, same as lanes 3
and 8, in the presence of 15 mM DTT; lanes 5, 6 and 10, 11, 1 mM NEM;
in the absence (lanes 5 and 10) or presence (lanes 6 and 11) of 15 mM
DTT. C indicates the control assay where no enzyme was added (lane 1).
b, modification of cysteine residues on denatured protein. Both M.
smegmatis and E. coli enzymes were denatured with 6 M guanidium
HCl (lanes 3 and 10) and renatured as mentioned under “Experimental
Procedures” (lanes 4 and 9). The denatured M. smegmatis and E. coli
enzymes were treated with 100 mM MMTS (lanes 5, 6, 12, and 13) and
1 mM NEM (lanes 7, 8, 14, and 15). 15 mM DTT is present in lanes 6, 8,
13, and 15. All the modified fractions were renatured by extensive
dialysis. E. coli enzyme does not regain the activity when dialyzed in
the absence of Zn21 (lane 11). Lane 1 is the substrate pUC19 DNA and
lane 2, activity of the native M. smegmatis enzyme.
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primary sequence of the two proteins would require the molec-
ular characterization of the gene for topoisomerase I from M.
smegmatis. In our assessment of various biochemical proper-
ties and reactions of the enzyme, we have compared the results
with the E. coli enzyme, arguably the prototype molecule. In
many respects, the enzyme is similar to topoisomerase I from
E. coli: 1) DNA relaxation, catenation, and knotting reactions;
2) absolute requirement for Mg21 ion; 3) covalent linkage to the
59-end of the nicked DNA; 4) tyrosine at the active site etc. The
mycobacterial enzyme, however, displays certain different
characteristics with respect to: 1) pH optima (17); 2) thermal
stability; 3) effect of spermidine on the enzyme activity; and 4)
role of cysteines in catalysis.
A rather surprising feature of the mycobacterial enzyme is
its stability. The purified enzyme is active on long periods of
storage and over broad pH range. Higher thermostability of the
enzyme could as well be a reflection of the retention of activity
over long duration on storage. Similar behavior is observed
with partially purified topoisomerase I from M. tuberculosis
H37Ra. We have considered the following points to explain
some of these attributes of the enzyme. Many mycobacterial
species live and survive in hostile environment within the
macrophages of the host. Furthermore, free living mycobacte-
ria exhibit relatively slow growth rates. The cell division time
ranges from a few hours to 24 h in different species (37).
Studies have shown that metabolic processes are slow in this
group of organisms with lower rates of reactions (38). Thus,
once synthesized, it is important that the key enzymes are
relatively stable over a long period of time in this group of
bacteria.
Another unexpected outcome of our analysis of the enzyme is
that cysteines do not have a role in DNA relaxation activity.
This is in contrast to the E. coli topoisomerase I, wherein 12
cysteine residues coordinate three Zn21 atoms to form zinc-
finger like structures involved in DNA binding. The derived
amino acid sequence of topoisomerase I from M. tuberculosis
(33) does not have a cysteine cluster found in E. coli (Fig. 9).
Five cysteine residues are found in the entire sequence of M.
tuberculosis enzyme. M. smegmatis topoisomerase I also con-
tains only 5 cysteines based on our cysteine estimation results.
We have considered the possibility that coordination could be
through histidines in the mycobacterial enzyme. Our histidine
modification experiments rule out a role for histidine as well.
Moreover, Zn21 blotting studies using radioactive Zn21 do not
show binding of zinc atoms to topoisomerase I from M. smeg-
matis or M. tuberculosis. Furthermore, o-phenanthroline, a
known zinc chelator also does not inhibit the enzyme activity.
Thus it seems likely that the binding to DNA could be mediated
by some other structural motif in the protein. This particular
difference in DNA binding characteristic, among other differ-
ences between the enzymes, form the basis to identify inhibi-
tors of the enzyme activity.
Many DNA transaction enzymes function in two modes, pro-
cessive or distributive. For example, DNA polymerase III (or
DNA polymerase d in eukaryotes) is a highly processive enzyme
where as polymerase II (or DNA polymerase b in eukaryotes)
functions distributively (39). Here we show that, depending on
the cationic environment, mycobacterial topoisomerase I can
switch from one mode to the other. We have assessed this
characteristic by using two plasmids of different size as sub-
strates. High concentration of Mg21 could decrease the affinity
of the enzyme to the substrate, thereby facilitating the “fall off”
the enzyme from the initial plasmid. Currently no estimates
of free Mg21 in mycobacteria is available. Given the concen-
tration of intracellular free Mg21 in E. coli to be 1–2 mM (40)
and if this applies to other bacteria as well, it is likely that
the enzyme predominantly exhibits processive behavior in
vivo. The ability of the enzyme to switch from one mode to the
other in intracellular milieu may as well be an important
characteristic.
One of the significant observations reported in this article is
stimulation of enzyme activity by SSB. Although topoisomer-
ase I is known to prefer single-stranded DNA, the natural
substrate is the supercoiled form which is predominantly dou-
ble-stranded. SSB, possibly by virtue of its ability to stabilize
the single-stranded regions in DNA, stimulates the enzyme
activity. Support for this functional cooperation between topoi-
somerase I and SSB also comes from studies where an SSB
allele is shown to influence DNA supercoiling levels in the cells
(41). One would expect increased local concentration of both
topoisomerase I and SSB at regions of DNA actively involved in
replication process. More recently SSB has been implicated in
other important biological processes. E. coli SSB is shown to
have a specific role in transcription activation of bacteriophage
N4 promoters (42, 43). The protein could also have a role in
influencing uracil DNA glycosylase-mediated excision reac-
tions (44). The stimulation of topoisomerase I relaxation activ-
ity could be yet another function of SSB in vivo. It is likely that
some of the other DNA transaction proteins could be involved
in functional cooperation with topoisomerases.
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